Search Results - "Eichenauer, D."

Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Eichenauer, D A, Aleman, B M P, André, M, Federico, M, Hutchings, M, Illidge, T, Engert, A, Ladetto, M

Get full text

Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Eichenauer, D A, Engert, A, André, M, Federico, M, Illidge, T, Hutchings, M, Ladetto, M

Get full text

Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Eichenauer, D.A., Engert, A., Dreyling, M.

Get full text

PET-2-guided escalated BEACOPP for advanced nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the randomized German Hodgkin Study Group HD18 study by Eichenauer, D.A., Kreissl, S., Bühnen, I., Baues, C., Kobe, C., van Heek, L., Goergen, H., Fuchs, M., Hartmann, S., von Tresckow, B., Engert, A., Borchmann, P.

Get full text

Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial by Behringer, K., Thielen, I., Mueller, H., Goergen, H., Eibl, A.D., Rosenbrock, J., Halbsguth, T., Eichenauer, D.A., Fuchs, M., Reiners, K.S., Renno, J.H., van der Ven, K., Kuehr, M., von Wolff, M., Diehl, V., Engert, A., Borchmann, P.

“…In the HD14 trial, 2× BEACOPPescalated + 2× ABVD (2 + 2) has improved the primary outcome. Compared with 4× ABVD, this benefit might be compromised by more…”
Get full text

Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Engert, A., Eichenauer, D. A., Dreyling, M.

Get full text

Proposal for participation in intensive care and emergency medicine studies for patients unable to give informed consent (Cologne Model) by Kochanek, M, Grass, G, Böll, B, Eichenauer, D A, Shimabukuro-Vornhagen, A, Hallek, M, Zander, T, Mertens, J, Voltz, R

“…When conducting clinical trials in intensive care and emergency medicine, physicians, ethics committees, and legal experts have differing views regarding the…”
Get full text

Sexual quality of life in Hodgkin Lymphoma: a longitudinal analysis by the German Hodgkin Study Group by Behringer, K, Müller, H, Görgen, H, Flechtner, H-H, Brillant, C, Halbsguth, T V, Thielen, I, Eichenauer, D A, Schober, T, Nisters-Backes, H, Fuchs, M, Engert, A, Borchmann, P

“…Background: Health-related quality of life (HRQoL) comprises different domains of physical, mental, and social well-being. In this analysis, we focus on sexual…”
Get full text

Management of an adult patient with sickle cell disease and acute chest syndrome by veno-venous extracorporeal membrane oxygenation by Al-Sawaf, O., Köhler, P., Eichenauer, D. A., Böll, B., Kochanek, M., Shimabukuro-Vornhagen, A.

Get full text

Ofatumumab in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: results of a phase II study from the German Hodgkin study group by Eichenauer, D A, Goergen, H, Plütschow, A, Wongso, D, Behringer, K, Kreissl, S, Thielen, I, Halbsguth, T, Bröckelmann, P J, Fuchs, M, Böll, B, von Tresckow, B, Borchmann, P, Engert, A

Get full text

Hodgkin's lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up by Engert, A., Eichenauer, D. A., Dreyling, M.

Get full text

Hemophagocytic lymphohistiocytosis in critically ill patients by Eichenauer, D A, Lachmann, G, La Rosée, P

“…Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammation syndrome. In adults, secondary HLH is mostly observed. HLH is often triggered by infections,…”
Get full text

TNF-α-converting enzyme (TACE ADAM17)-dependent loss of CD30 induced by proteasome inhibition through reactive oxygen species by Vahdat, A M, Reiners, K S, Simhadri, V L, Eichenauer, D A, Böll, B, Chalaris, A, Simhadri, V R, Wiegmann, K, Krell, H-W, Rose-John, S, Engert, A, von Strandmann, E P, Hansen, H P

“…Combinations with proteasome inhibitors are currently being investigated to improve the therapy of hematological malignancies. We previously found that…”
Get full text

EBEACOPP WITH OR WITHOUT RITUXIMAB IN INTERIM‐PET‐POSITIVE ADVANCED‐STAGE HODGKIN LYMPHOMA: UPDATED RESULTS OF THE INTERNATIONAL, RANDOMIZED PHASE 3 GHSG HD18 TRIAL by Borchmann, P., Goergen, H., Kobe, C., Eichenauer, D., Greil, R., Lohri, A., Novak, U., Markova, J., Beck, H., Meissner, J., Zijlstra, J.M., Ostermann, H., Feuring‐Buske, M., Dierlamm, J., Eich, H., Baues, C., Rosenwald, A., Fuchs, M., Diehl, V., Kuhnert, G., Dietlein, M., Engert, A.

Get full text

Neue Entwicklungen in der Therapie des fortgeschrittenen klassischen Hodgkin-Lymphoms by Kreissl, S., Eichenauer, D. A., Meissner, J., Topp, M. S., Engert, A., Borchmann, P.

“…Zusammenfassung Hintergrund Das Gesamtüberleben von Patienten mit fortgeschrittenem Hodgkin-Lymphom (HL), die mit dem aktuellen Standard der Deutschen Hodgkin…”
Get full text

Neue Entwicklungen in der Therapie des fortgeschrittenen Hodgkin-Lymphoms by Kreissl, S., Eichenauer, D., Borchmann, P.

“…Zusammenfassung Hintergrund Das Gesamtüberleben von Patienten mit fortgeschrittenem Hodgkin-Lymphom (HL) unter dem aktuellen Standard der German Hodgkin Study…”
Get full text

Die hämophagozytische Lymphohistiozytose bei kritisch kranken Patienten by Eichenauer, D. A., Lachmann, G., La Rosée, P.

“…Bei der hämophagozytischen Lymphohistiozytose (HLH) handelt es sich um ein Hyperinflammationssyndrom bedingt durch aberrant aktivierte Makrophagen und…”
Get full text

Corrigendum to “Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial”: Annals of Oncology 2012; 23: 1818-1825 by Behringer, K., Thielen, I., Mueller, H., Goergen, H., Eibl, A.D., Rosenbrock, J., Halbsguth, T., Eichenauer, D.A., Fuchs, M., Reiners, K.S., Renno, J.H., van der Ven, K., Kuehr, M., von Wolff, M., Diehl, V., Engert, A., Borchmann, P.

Get full text

Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up: ESMO Updated Clinical Practice Guidelines by EICHENAUER, D. A, ENGERT, A, DREYLING, M

Get full text

Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up: ESMO Updated Clinical Practice Guidelines by EICHENAUER, D. A, ENGERT, A, ANDRE, M, FEDERICO, M, ILLIDGE, T, HUTCHINGS, M, LADETTO, M

Get full text